FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Ac...

  • U.S. Food and Drug Administration
  • September 2, 2026
  • ID: D-0786-2026

Drug Enforcement Report Details

Recall NumberD-0786-2026
Recalling FirmACCORD HEALTHCARE, INC.
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternNationwide within the United States
StatusOngoing
Product Description

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.

Reason for Recall

Subpotent Drug

Code Information

Lot #: D2402337, Exp. Date 10/31/2026.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.